|
HUP9902721A2
(hu)
*
|
1997-11-25 |
1999-12-28 |
The Procter & Gamble Co. |
Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület
|
|
CA2343038A1
(en)
*
|
1998-09-28 |
2000-04-06 |
Maria Emanuel Ryan |
A novel inhibitor of cataract formation
|
|
US6914057B1
(en)
|
1998-09-28 |
2005-07-05 |
The Research Foundation Of State University Of New York |
Inhibitor of cataract formation
|
|
WO2002072146A2
(en)
*
|
2001-03-12 |
2002-09-19 |
Novartis Ag |
Combination of nateglinide or repaglinide with at least one further antidiabetic compound
|
|
US20040115261A1
(en)
*
|
2001-04-05 |
2004-06-17 |
Ashley Robert A. |
Controlled delivery of tetracycline compounds and tetracycline derivatives
|
|
FR2826278B1
(fr)
*
|
2001-06-20 |
2005-03-25 |
Lipha |
Utilisation d'agents antidiabetiques pour fabriquer un medicament ayant un effet cicatrisant
|
|
ES2275889T3
(es)
*
|
2001-06-20 |
2007-06-16 |
Merck Sante |
Utilizacion de agentes antidiabeticos para fabricar un medicamento que tiene un efecto cicatrizante.
|
|
EP2332547A1
(en)
|
2001-07-13 |
2011-06-15 |
Paratek Pharmaceuticals, Inc. |
Tetracyclines for the treatment of inflammatory bowel disease
|
|
WO2003059253A2
(en)
*
|
2001-12-21 |
2003-07-24 |
Smithkline Beecham Corporation |
Compositions and methods for altering glucose production
|
|
EP2311796A1
(en)
|
2002-01-08 |
2011-04-20 |
Paratek Pharmaceuticals, Inc. |
4-dedimethylamino tetracycline compounds
|
|
WO2003075857A2
(en)
|
2002-03-08 |
2003-09-18 |
Paratek Pharmaceuticals, Inc. |
Amino-methyl substituted tetracycline compounds
|
|
EA200401232A1
(ru)
|
2002-03-21 |
2005-12-29 |
Пэрэтек Фамэсьютикэлс, Инк. |
Замещенные соединения тетрациклина, фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта
|
|
KR101089429B1
(ko)
|
2002-07-12 |
2011-12-07 |
파라테크 파마슈티컬스, 인크. |
3, 10, 및 12ａ 치환된 테트라시클린 화합물
|
|
WO2004091483A2
(en)
|
2003-04-07 |
2004-10-28 |
Shire Laboratories, Inc. |
Once daily formulations of tetracyclines
|
|
KR101228706B1
(ko)
|
2003-07-09 |
2013-02-01 |
파라테크 파마슈티컬스, 인크. |
치환된 테트라시클린 화합물
|
|
EP1656341A1
(en)
|
2003-07-09 |
2006-05-17 |
Paratek Pharmaceuticals, Inc. |
Prodrugs of 9-aminomethyl tetracycline compounds
|
|
EP1716101A1
(en)
*
|
2004-01-15 |
2006-11-02 |
Paratek Pharmaceuticals, Inc. |
Aromatic a-ring derivatives of tetracycline compounds
|
|
CA2585418A1
(en)
|
2004-10-25 |
2006-05-04 |
Paratek Pharmaceuticals, Inc. |
4-aminotetracyclines and methods of use thereof
|
|
EP2269978A3
(en)
|
2004-10-25 |
2011-09-21 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
|
CA2616224A1
(en)
*
|
2005-07-21 |
2007-02-01 |
Paratek Pharmaceuticals, Inc. |
10-substituted tetracyclines and methods of use thereof
|
|
US20070098763A1
(en)
*
|
2005-10-11 |
2007-05-03 |
Sinnott Robert A |
Soluble Fiber Combinations for Weight Control and Improving Parameters of Cardiovascular Health
|
|
CA2673486C
(en)
*
|
2006-12-21 |
2015-09-08 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for treatment of inflammatory skin disorders
|
|
EP3045449A1
(en)
|
2006-12-21 |
2016-07-20 |
Paratek Pharmaceuticals, Inc. |
Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
|
|
WO2008134048A2
(en)
*
|
2007-04-27 |
2008-11-06 |
Paratek Pharmaceuticals, Inc. |
Methods for synthesizing and purifying aminoalkyl tetracycline compounds
|
|
EA201070048A1
(ru)
*
|
2007-07-06 |
2010-10-29 |
Паратек Фармасьютикалс, Инк. |
Способы синтеза замещённых соединений тетрациклина (варианты)
|
|
TWI585071B
(zh)
|
2008-05-19 |
2017-06-01 |
派洛泰克藥物股份有限公司 |
四環素化合物之甲苯磺酸鹽及同素異形體
|
|
PL3000805T3
(pl)
|
2008-08-08 |
2018-04-30 |
Tetraphase Pharmaceuticals, Inc. |
C7-fluoro podstawione związki tetracyklinowe
|
|
ES2627772T3
(es)
|
2009-05-08 |
2017-07-31 |
Tetraphase Pharmaceuticals, Inc. |
Compuestos de tetraciclina
|
|
WO2011025982A2
(en)
|
2009-08-28 |
2011-03-03 |
Tetraphase Pharmaceuticals, Inc. |
Tetracycline compounds
|
|
ES2621409T3
(es)
|
2010-03-31 |
2017-07-04 |
Tetraphase Pharmaceuticals, Inc. |
Compuestos policíclicos de tetraciclina
|
|
AU2013308504B2
(en)
|
2012-08-31 |
2016-11-10 |
Tetraphase Pharmaceuticals, Inc. |
Tetracycline compounds
|
|
US9171343B1
(en)
|
2012-09-11 |
2015-10-27 |
Aseko, Inc. |
Means and method for improved glycemic control for diabetic patients
|
|
US9897565B1
(en)
|
2012-09-11 |
2018-02-20 |
Aseko, Inc. |
System and method for optimizing insulin dosages for diabetic subjects
|
|
US9486580B2
(en)
|
2014-01-31 |
2016-11-08 |
Aseko, Inc. |
Insulin management
|
|
US9898585B2
(en)
|
2014-01-31 |
2018-02-20 |
Aseko, Inc. |
Method and system for insulin management
|
|
US11081226B2
(en)
|
2014-10-27 |
2021-08-03 |
Aseko, Inc. |
Method and controller for administering recommended insulin dosages to a patient
|
|
JP6989262B2
(ja)
|
2014-10-27 |
2022-01-05 |
アセコー インコーポレイテッド |
皮下外来患者管理
|
|
AU2016308953B2
(en)
|
2015-08-20 |
2020-09-10 |
Glytec, Llc |
Diabetes management therapy advisor
|
|
KR102880712B1
(ko)
|
2016-10-19 |
2025-11-03 |
테트라페이즈 파마슈티컬스, 인코포레이티드 |
에라바사이클린의 결정질 형태
|
|
WO2020097450A1
(en)
|
2018-11-09 |
2020-05-14 |
Tetraphase Pharmaceuticals, Inc. |
Polymorphic forms of a compound and uses thereof
|
|
KR20220098682A
(ko)
|
2019-05-14 |
2022-07-12 |
타임, 인크. |
암을 치료하기 위한 조성물 및 방법
|
|
WO2021207487A1
(en)
*
|
2020-04-08 |
2021-10-14 |
Hoffman Technologies Llc |
Methods of treating conditions characterized by insulin deficiency in animals
|
|
US10905698B1
(en)
|
2020-05-14 |
2021-02-02 |
Tyme, Inc. |
Methods of treating SARS-COV-2 infections
|